|
| Trans-4-Methylcyclohexanecarboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| Bis(carboxycyclopentadienyl) Iron |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| 3-Noradamantanecarboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| (4E)-2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzylidene)-1,3-oxazol-5(4H)-one |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| (4E)-4-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)methylidene]-2-(4-methylphenyl)-1,3-oxazolidin-5-one |
|
Pseudomonas
Yersinia |
TTSS (Type III secretion system)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother
|
|
| 2-hydroxy-5-[5-[(E)-3-oxo-3-[[3-oxo-3-[(3-phenyl-1,2,4-thiadiazol-5-yl)amino]propyl]amino]prop-1-enyl]furan-2-yl]benzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
| 2-hydroxy-5-[5-[(E)-3-[[3-[[3-(4-hydroxyphenyl)-1,2,4-thiadiazol-5-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]benzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
| 5-[5-[(E)-3-[[(1S)-1-carboxy-2-(4-nitrophenyl)ethyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
| 5-[5-[(E)-3-[[3-[[4-(3,4-difluorophenyl)-1,3-thiazol-2-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
| | | |
| | | |
| | | |
